Ojone Illah is currently a PhD Student at University College London. She qualified as a medical doctor in 2014 at the University of Warwick. She has undergone clinical training in Obstetrics and Gynaecology and plans to subspecialize in Gynaecological Oncology. Her research interests are in global women’s cancer and addressing disparities in women's cancers. Her PhD, for which she was awarded a research excellence scholarship, is investigating epigenetic means of cervical cancer screening in understudied African populations. Before her medical degree, she completed a BSc in Physiology at the University of Edinburgh. Her final-year laboratory project investigated factors that affect the expression of a receptor within the renal tubular collecting system.
Adeola Olaitan was qualified at the University College London Hospital in 1987 before going on to be awarded a Medical Doctorate from the same university. She undertook further training in General Obstetrics and Gynaecology followed by a sub-speciality Fellowship in Gynaecological Oncology at St Michael’s Hospital, Bristol. She is a Fellow of the Royal College of Obstetricians and Gynaecologists. She was appointed as a consultant at the University College London Hospital (UCLH) in 2002 and has previously been the clinical lead of the Gynaecological Cancer Centre. She is a member of the British Gynaecological Cancer Society and the International Gynaecological Cancer Society. She is also a medical expert for The Eve Appeal Cancer Charity and Jo's Trust Cervical Cancer Charity and has been the media spokesperson for the NHS Cervical Screening Programme. She is presently an Honorary Associate Professor at the University College London Hospital and has written over 50 peer-reviewed publications and book chapters. She is accredited in colposcopy of the cervix for patients with abnormal smear results and has a particular interest in patients with cervical cancer, endometrial (womb) cancer, ovarian cancer, and vulval cancer. She is a specialist in minimally invasive surgery and in maintaining quality of life in patients following cancer treatment.
Aleksandra Gentry-Maharaj is a Principal Research Fellow, based both at the Institute of Clinical Trials and Methodology (ICTM) and the Institute for Women’s Health (IfWH). Since August 2023, she has been the Head of the Research Department of Women’s Cancer (IfWH). She joined the Gynaecological Cancer Research Centre as a Research Associate in 2003, first based at Barts and, since April 2004, at the Institute for Women's Health. Throughout her entire appointment at UCL, she was key to the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS). Since 2006, she has co-set up and coordinated the UK Ovarian Cancer Population (UKOPS) study. Since 2017, she has taken on the role of the UKCTOCS Project Lead and, since 2021, the role of the ICON8B and Add-Aspirin Project Co-lead. Alex took on the role of the CRUK ACED Co-Director of Research Domain Trials in 2022. In 2023, she joined the Steering Committee of the International 100K+ Cohort Consortium. She is the author of more than 205 papers in high-impact journals and has contributed to numerous textbooks and reviews. She is an Editor for BMC Women’s Health and Diagnostics. She has presented her work at national and key international meetings (ESGO Istanbul 2005, IGCS Santa Monica 2006, ESGO Berlin 2007, IMS Madrid 2008, ESGO Nice 2015, and BGCS, amongst others).
